Lynn Atuyambe Atuyambe
ID: UNCST-2021-R012602
|
Exploring the facilitators and barriers of coverage, access, and use of HPV vaccination services among girls aged 10-14 years in Uganda
REFNo: SS3473ES
4. Determine the overall national performance of HPV vaccination in Uganda,3. Describe Uganda’s overall context of cervical cancer and HPV vaccination in cancer prevention and adolescent health,2. To document the challenges facing the least performing 12 districts, the interventions applied through the World Bank Group grant-funded activities,1. To explore the facilitators and barriers of coverage, access, and use of HPV first and second dose (full dose vaccination) services among girls aged 10-14 years in Uganda ,
|
Uganda |
2025-03-14 17:53:23 |
2028-03-14 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Felix Oyania
ID: UNCST-2021-R013492
|
Impact of an outreach program on reduction of pediatric surgical disease in a refugee population
REFNo: HS5568ES
Aim 1: Evaluate the impact of an outreach program on reduction of pediatric surgical disease and averted disability (a) in comparison to a historical cohort (b).
Aim 2: Assess acquisition of knowledge and behavior change of refugee settlement healthcare providers in identifying and referring pediatric patients with surgically treatable disease.
|
Uganda |
2025-03-14 17:50:38 |
2028-03-14 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Wilber Sabiiti
ID: UNCST-2024-R016293
|
Field clinical evaluation of the NG-Test Point of Care lateral flow device (LFD) for monkeypox diagnosis in Uganda
REFNo: HS5602ES
To evaluate detection performance and clinical agreement of Rapid Point of Care (POC) antigen assay for diagnosis of mpox among clinically suspected patients in healthcare facilities in Kampala, Wakiso, Mukono, and Nakasongola districts in Uganda.
Specific objective 1
To determine the diagnostic sensitivity, specificity, & predictive values of the Rapid NG-Test antigen
assay in comparison to PCR and sequencing among patients with mpox
Specific objective 2
To identify MPXV clade (s) circulating among patients with mpox through virologic metagenomic
sequencing
|
Uganda |
2025-03-14 17:48:15 |
2028-03-14 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
JOLLY KAKKAYI NYESIGIRE
ID: UNCST-2024-R004296
|
TALENT MANAGEMENT PRACTICES AND EMPLOYEE PERFORMANCE IN SELECTED PUBLIC UNIVERSITIES IN UGANDA
REFNo: SS3682ES
The objectives of this study are:
1. To examine the influence of talent attractiveness on employees performance in Public Universities;
2. To investigate the effect of talent motivation on employees performance in Public Universities;
3. To explore the effect of talent development on the performance of employees in Public Universities;
4. To establish the relationship between talent retention and employees performance in Public Universities.
5. To examine the moderation effect of employee commitment on the relationship between talent management practices and employee performance.
|
Uganda |
2025-03-14 17:45:15 |
2028-03-14 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
.jpg)
|
Victor Musiime
ID: UNCST-2021-R013794
|
A global phase 3, randomised, double-blind and placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease
REFNo: HS5637ES
1. To demonstrate superiority of
treatment with etavopivat
versus placebo in adolescents
and adults with SCD.
2. To evaluate clinical efficacy
measures of etavopivat treatment
versus placebo in adolescents
and adults with SCD
3. To assess clinically meaningful
improvement in fatigue and
functional exercise capacity
and QOL measures of
adolescents and adults with
SCD taking etavopivat
treatment compared to placebo
|
Uganda |
2025-03-14 17:26:26 |
2028-03-14 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|